Redhill Biopharma (RDHL)
(Delayed Data from NSDQ)
$0.46 USD
0.00 (-0.04%)
Updated May 31, 2024 03:56 PM ET
After-Market: $0.45 -0.01 (-1.77%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
Redhill Biopharma Ltd. [RDHL]
Reports for Purchase
Showing records 221 - 228 ( 228 total )
Company: Redhill Biopharma Ltd.
Industry: Medical - Drugs
Visibility Increasing for RHB-101, Upside to our model
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Company: Redhill Biopharma Ltd.
Industry: Medical - Drugs
MORNING CALL SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Redhill Biopharma Ltd.
Industry: Medical - Drugs
1Q13 Recap - Largely as Expected, Buy for RHB-104
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Company: Redhill Biopharma Ltd.
Industry: Medical - Drugs
MORNING CALL SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Redhill Biopharma Ltd.
Industry: Medical - Drugs
Company: Redhill Biopharma Ltd.
Industry: Medical - Drugs
MORNING CALL SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Redhill Biopharma Ltd.
Industry: Medical - Drugs
We launch coverage with a Buy rating and a $20/share price target
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S